Review



anti cleaved caspase 9  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    Cell Signaling Technology Inc anti cleaved caspase 9
    Anti Cleaved Caspase 9, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 8888 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cleaved+caspase+9/Caspase-9+Antibody/pmc12666026-25-5-16
    Average 97 stars, based on 8888 article reviews
    anti cleaved caspase 9 - by Bioz Stars, 2026-10
    97/100 stars

    Images

    Related Articles

    Incubation:

    Article Title: FYCO1 improves postischemic cardiac remodeling via enhanced autophagic flux and attenuation of proinflammatory signaling
    Article Snippet: .. For quantification of total protein membranes were incubated in Ponceau S (# P7170, Sigma), before being blocked in 5% BSA for 1–2 h. Membranes were incubated overnight at 4°C with antibodies anti-FYCO1 (NovusBiologicals, # 47266), anti-LC3B (CellSignaling, #2775), anti-p62 (CellSignaling, #5114), anti-Atg5 (CellSignaling, #2630), anti-Rab7 (Sigma, # R4779), anti-Bcl-2 (Proteintech, # 68103), anti-Bax (CellSignaling, #14796), Caspase 3 (CellSignaling, #9662), cleaved Caspase 3 (CellSignaling, #9661), Caspase 7 (CellSignaling, #9492), cleaved Caspase 7 (CellSignaling, #9491), Caspase 9 (CellSignaling, #9508), or cleaved Caspase 9 (CellSignaling, #9507). ..

    Article Title: Hematopoietic Cell Kinase Promotes Cerebral Ischemic Injury and Mitochondrial Dysfunction via p38 Activation in Ischemic Stroke.
    Article Snippet: Ischemic stroke is a leading cause of death and permanent disability worldwide.. There is an urgent need to identify novel therapeutic targets.. Through bioinformatics analysis of Gene Expression Omnibus (GEO) datasets and the construction of protein–protein interaction (PPI) network, we identified hematopoietic cell kinase (HCK) as a key regulatory factor in ischemic stroke.

    Article Title: NUP205 Stabilized YAP1 Protein to Stimulate Growth of Hepatocellular Carcinoma Cells in vitro and in vivo
    Article Snippet: .. The membrane was incubated overnight at 4 °C with primary antibodies raised against NUP205, YAP1 (Proteintech, China), Bcl-2, BAX, caspase-9, Cleaved PARP, Cleaved caspase-3, Cleaved caspase-7 and Cleaved caspase-9 (Cell Signaling Technology, USA) and with secondary antibodies (HRP-conjugated goat polyclonal anti-rabbit and HRP-conjugated goat polyclonal anti-mouse IgG, Cell Signaling Technology, MA, USA, 1:5000 in TBST) for 2h at room temperature. .. Enhanced chemiluminescence reagents (Millipore, MA, USA) were used for detection by Gel (2000) image analyzer (Bio-Rad, CA, USA).

    Article Title: Identification and Validation of miR-206-3p Targeting WT-1 Promotes Membranous Nephropathy Through a Comprehensive Bioinformatics and Machine Learning Algorithm.
    Article Snippet: Membranous nephropathy (MN), a major cause of endstage renal disease, has limited therapeutics due to unclear targets.. MicroRNAs (miRs) play critical roles in various diseases, but their role in MN remains unknown.. This study utilizes a series of public databases, bioinformatics tools, and validation methods to identify key miRs and molecular mechanisms involved in MN.

    Membrane:

    Article Title: NUP205 Stabilized YAP1 Protein to Stimulate Growth of Hepatocellular Carcinoma Cells in vitro and in vivo
    Article Snippet: .. The membrane was incubated overnight at 4 °C with primary antibodies raised against NUP205, YAP1 (Proteintech, China), Bcl-2, BAX, caspase-9, Cleaved PARP, Cleaved caspase-3, Cleaved caspase-7 and Cleaved caspase-9 (Cell Signaling Technology, USA) and with secondary antibodies (HRP-conjugated goat polyclonal anti-rabbit and HRP-conjugated goat polyclonal anti-mouse IgG, Cell Signaling Technology, MA, USA, 1:5000 in TBST) for 2h at room temperature. .. Enhanced chemiluminescence reagents (Millipore, MA, USA) were used for detection by Gel (2000) image analyzer (Bio-Rad, CA, USA).

    Infection:

    Article Title: Selective Elimination of Myeloid HIV Reservoirs by Targeting Pro-survival Pathways.
    Article Snippet: .. Macrophages with or without HIV-1 infection as above were stimulated for 24 h with 0.1 μM IDB or vehicle control, followed by Western blot analyses as described.7 Cell lysates were used for SDS-PAGE and Western blot analyses by probing with monoclonal antibodies to CASPASE-9 (1:1,000, M054-3, Medical & Biological Laboratories) and CASPASE-7 (1:1,000, M053-3, Medical & Biological Laboratories), cleaved CASPASE-9 (1:1,000, 52873s, Cell Signaling), CASPASE-3 (1:1,000, 9665s, Cell Signaling), cleaved CASPASE-3 (1:1,000, 9501s, Cell Signaling), CASPASE-6 (1:1,000, 9762s, Cell Signaling), BCL-2 (1:1,000, 4223s, Cell Signaling), BCL-xL (1:1,000, 2762s, Cell Signaling), MCL-1 (1:1,000, 5453s, Cell Signaling), BAK (1:1,000, 12105s, Cell Signaling), BAX (1:1,000, 2772s, Cell Signaling), LC3 A/B (1:1000, 4108s, Cell Signaling) or monoclonal anti--Actin (1:5,000, sc-47778, Santa Cruz Biotechnology). .. The blots were then incubated with HRP-conjugated goat anti-Mouse IgG1 (1:5,000, 1070-05, Southern Biotech) or HRP-conjugated goat anti-Rabbit IgG (1:5,000, ab6721, Abcam) and developed using SuperSignal West Dura Extended Duration Substrate (ThermoFisher).

    Control:

    Article Title: Selective Elimination of Myeloid HIV Reservoirs by Targeting Pro-survival Pathways.
    Article Snippet: .. Macrophages with or without HIV-1 infection as above were stimulated for 24 h with 0.1 μM IDB or vehicle control, followed by Western blot analyses as described.7 Cell lysates were used for SDS-PAGE and Western blot analyses by probing with monoclonal antibodies to CASPASE-9 (1:1,000, M054-3, Medical & Biological Laboratories) and CASPASE-7 (1:1,000, M053-3, Medical & Biological Laboratories), cleaved CASPASE-9 (1:1,000, 52873s, Cell Signaling), CASPASE-3 (1:1,000, 9665s, Cell Signaling), cleaved CASPASE-3 (1:1,000, 9501s, Cell Signaling), CASPASE-6 (1:1,000, 9762s, Cell Signaling), BCL-2 (1:1,000, 4223s, Cell Signaling), BCL-xL (1:1,000, 2762s, Cell Signaling), MCL-1 (1:1,000, 5453s, Cell Signaling), BAK (1:1,000, 12105s, Cell Signaling), BAX (1:1,000, 2772s, Cell Signaling), LC3 A/B (1:1000, 4108s, Cell Signaling) or monoclonal anti--Actin (1:5,000, sc-47778, Santa Cruz Biotechnology). .. The blots were then incubated with HRP-conjugated goat anti-Mouse IgG1 (1:5,000, 1070-05, Southern Biotech) or HRP-conjugated goat anti-Rabbit IgG (1:5,000, ab6721, Abcam) and developed using SuperSignal West Dura Extended Duration Substrate (ThermoFisher).

    Western Blot:

    Article Title: Selective Elimination of Myeloid HIV Reservoirs by Targeting Pro-survival Pathways.
    Article Snippet: .. Macrophages with or without HIV-1 infection as above were stimulated for 24 h with 0.1 μM IDB or vehicle control, followed by Western blot analyses as described.7 Cell lysates were used for SDS-PAGE and Western blot analyses by probing with monoclonal antibodies to CASPASE-9 (1:1,000, M054-3, Medical & Biological Laboratories) and CASPASE-7 (1:1,000, M053-3, Medical & Biological Laboratories), cleaved CASPASE-9 (1:1,000, 52873s, Cell Signaling), CASPASE-3 (1:1,000, 9665s, Cell Signaling), cleaved CASPASE-3 (1:1,000, 9501s, Cell Signaling), CASPASE-6 (1:1,000, 9762s, Cell Signaling), BCL-2 (1:1,000, 4223s, Cell Signaling), BCL-xL (1:1,000, 2762s, Cell Signaling), MCL-1 (1:1,000, 5453s, Cell Signaling), BAK (1:1,000, 12105s, Cell Signaling), BAX (1:1,000, 2772s, Cell Signaling), LC3 A/B (1:1000, 4108s, Cell Signaling) or monoclonal anti--Actin (1:5,000, sc-47778, Santa Cruz Biotechnology). .. The blots were then incubated with HRP-conjugated goat anti-Mouse IgG1 (1:5,000, 1070-05, Southern Biotech) or HRP-conjugated goat anti-Rabbit IgG (1:5,000, ab6721, Abcam) and developed using SuperSignal West Dura Extended Duration Substrate (ThermoFisher).

    SDS Page:

    Article Title: Selective Elimination of Myeloid HIV Reservoirs by Targeting Pro-survival Pathways.
    Article Snippet: .. Macrophages with or without HIV-1 infection as above were stimulated for 24 h with 0.1 μM IDB or vehicle control, followed by Western blot analyses as described.7 Cell lysates were used for SDS-PAGE and Western blot analyses by probing with monoclonal antibodies to CASPASE-9 (1:1,000, M054-3, Medical & Biological Laboratories) and CASPASE-7 (1:1,000, M053-3, Medical & Biological Laboratories), cleaved CASPASE-9 (1:1,000, 52873s, Cell Signaling), CASPASE-3 (1:1,000, 9665s, Cell Signaling), cleaved CASPASE-3 (1:1,000, 9501s, Cell Signaling), CASPASE-6 (1:1,000, 9762s, Cell Signaling), BCL-2 (1:1,000, 4223s, Cell Signaling), BCL-xL (1:1,000, 2762s, Cell Signaling), MCL-1 (1:1,000, 5453s, Cell Signaling), BAK (1:1,000, 12105s, Cell Signaling), BAX (1:1,000, 2772s, Cell Signaling), LC3 A/B (1:1000, 4108s, Cell Signaling) or monoclonal anti--Actin (1:5,000, sc-47778, Santa Cruz Biotechnology). .. The blots were then incubated with HRP-conjugated goat anti-Mouse IgG1 (1:5,000, 1070-05, Southern Biotech) or HRP-conjugated goat anti-Rabbit IgG (1:5,000, ab6721, Abcam) and developed using SuperSignal West Dura Extended Duration Substrate (ThermoFisher).

    Bioprocessing:

    Article Title: Selective Elimination of Myeloid HIV Reservoirs by Targeting Pro-survival Pathways.
    Article Snippet: .. Macrophages with or without HIV-1 infection as above were stimulated for 24 h with 0.1 μM IDB or vehicle control, followed by Western blot analyses as described.7 Cell lysates were used for SDS-PAGE and Western blot analyses by probing with monoclonal antibodies to CASPASE-9 (1:1,000, M054-3, Medical & Biological Laboratories) and CASPASE-7 (1:1,000, M053-3, Medical & Biological Laboratories), cleaved CASPASE-9 (1:1,000, 52873s, Cell Signaling), CASPASE-3 (1:1,000, 9665s, Cell Signaling), cleaved CASPASE-3 (1:1,000, 9501s, Cell Signaling), CASPASE-6 (1:1,000, 9762s, Cell Signaling), BCL-2 (1:1,000, 4223s, Cell Signaling), BCL-xL (1:1,000, 2762s, Cell Signaling), MCL-1 (1:1,000, 5453s, Cell Signaling), BAK (1:1,000, 12105s, Cell Signaling), BAX (1:1,000, 2772s, Cell Signaling), LC3 A/B (1:1000, 4108s, Cell Signaling) or monoclonal anti--Actin (1:5,000, sc-47778, Santa Cruz Biotechnology). .. The blots were then incubated with HRP-conjugated goat anti-Mouse IgG1 (1:5,000, 1070-05, Southern Biotech) or HRP-conjugated goat anti-Rabbit IgG (1:5,000, ab6721, Abcam) and developed using SuperSignal West Dura Extended Duration Substrate (ThermoFisher).



    Similar Products

    97
    Cell Signaling Technology Inc anti cleaved caspase 9
    Anti Cleaved Caspase 9, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cleaved+caspase+9/Caspase-9+Antibody/pmc12666026-25-5-16
    Average 97 stars, based on 1 article reviews
    anti cleaved caspase 9 - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    86
    Wanleibio anti cleaved caspase 9 rabbit pab
    Anti Cleaved Caspase 9 Rabbit Pab, supplied by Wanleibio, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cleaved+caspase+9/3+anti+caspase+cleaved/pm42106126-50-16-35
    Average 86 stars, based on 1 article reviews
    anti cleaved caspase 9 rabbit pab - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    86
    Affinity Biosciences cleaved caspase 9
    Cleaved Caspase 9, supplied by Affinity Biosciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cleaved+caspase+9/3+anti+caspase+cleaved/pmc12914111-39-8-70
    Average 86 stars, based on 1 article reviews
    cleaved caspase 9 - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    86
    Abmart Inc cleaved caspase 9 asp353 antibody
    mBH3@NPs preferentially induced mtApoptosis and immunogenic cell death in cancer cells (A) Flow cytometry analysis of cells positive for Annexin V and propidium iodide (PI) in cancer and non-cancer cell lines after treatment with PBS (control), NPs, naked Puma mRNA, and mPuma@NPs for 12 h ( n = 3). (B) Western blot analysis of mitochondrial apoptois pathway in CT-26 cells treated with control, NPs, mPuma@NPs, and mBim@NPs. Bax, Bcl-2, Bcl-x L , Mcl-1, caspase-3, cleaved caspase-3 (C-Cas3), caspase9, and cleaved caspase-9 (C-Cas9) proteins were detected. β-Actin was used as the loading control ( n = 3). (C) Confocal laser scanning microscopy (CLSM) images of the 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethyl-imidacarbocyanine (JC-1) probe in CT-26 cells after treatment with PBS (control), NPs, mPuma@NPs, and mBim@NPs for 12 h. Increased JC-1 monomer signal (green) and decreased JC-1 aggregate signal (red) indicate a decrease in mitochondrial membrane potential ( n = 3). Scale bars, 200 μm. (D) Flow cytometry analysis of cellular oxygen species (ROS) levels using 2,7-dichlorofluorescein diacetate (DCFH-DA) staining in CT-26 cells after 12 h incubation with PBS (control), NPs, naked mRNA, mPuma@NPs, and mBim@NPs ( n = 3). (E) CLSM images of CRT expression in B16-F10 and CT-26 cells after 12 h incubation with PBS (control), NPs, mPuma@NPs, and mBim@NPs ( n = 3). Scale bars, 20 μm. (F) Extracellular ATP and HMGB1 expression levels were analyzed by ELISA in B16-F10 cells after 12-h incubation with PBS (control), NPs, mPuma@NPs, and mBim@NPs ( n = 3). (G) Flow cytometry analysis and quantification of immune stimulation in BMDCs co-cultured with B16-F10 cells pretreated with PBS (control), NPs, mPuma@NPs, and mBim@NPs for 12 h, followed by 48-h co-culture ( n = 3). One-way ANOVA with Tukey’s multiple comparisons test was used for all statistical analyses. Data are presented as the mean ± SD. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; NS, not significant. See also  .
    Cleaved Caspase 9 Asp353 Antibody, supplied by Abmart Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cleaved+caspase+9/3+anti+caspase/pmc13130659-10-0-5
    Average 86 stars, based on 1 article reviews
    cleaved caspase 9 asp353 antibody - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc cleaved caspase 9 asp315 d8i9e rabbit mab
    CGF’s effect on cell cycle and apoptosis in CRC (A) Flow cytometry was used to analyze how CGF affects the cell cycle of HCT116 and HT29 cells at certain concentrations, with the percentage of cells in G1, S, and G2 phases shown in each panel. (B) Western blot analysis of the changes in cell cycle-related proteins CDK1, p-CDK1, and cyclin B1 in HCT116 and HT29 cells after CGF treatment. (C) RT-qPCR analysis of the relative expression levels of PUMA and NOXA genes in HCT116 and HT29 cells treated with different concentrations of CGF. (D) Western blot analysis of the changes in apoptosis-related proteins BCL2, PUMA, Noxa, C-caspase 9, and C-caspase 3 in HCT116 and HT29 cells after CGF treatment. (E) Flow cytometry was used to analyze apoptosis in HCT116 and HT29 cells treated with CGF. On the left is a representative plot showing apoptosis, utilizing Annexin V-FITC and PI double staining. Right: Analysis of early and late apoptosis in cells from each group using quantitative methods. (A–C and E) Data presentation is in the form of mean ± SEM. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; ∗∗∗∗ p < 0.0001.
    Cleaved Caspase 9 Asp315 D8i9e Rabbit Mab, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cleaved+caspase+9/Cleaved+Caspase-9+(Asp315)+Rabbit+mAb/pmc13018894-10-0-7
    Average 96 stars, based on 1 article reviews
    cleaved caspase 9 asp315 d8i9e rabbit mab - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc cleaved caspase 9
    Knockdown of LEF1 induces apoptosis in PAAD cells. A–C, Flow cytometry detection of apoptosis and apoptosis rate statistics: apoptosis rate was higher in AsPC-1/shLEF1 and BxPC-3/shLEF1. D–F, Calcein AM/PI staining assay results and statistics: the live cells decreased while the dead cells increased in AsPC-1/shLEF1 and BxPC-3/shLEF1. G, ATP production assay: the ATP production decreased in AsPC-1/shLEF1 and BxPC-3/shLEF1. H, LDH release assay showed an increase in LDH release in AsPC-1/shLEF1 and BxPC-3/shLEF1. I–M, WB results and quantitative analysis: the level of Bcl-2 protein decreased in AsPC-1/shLEF1 and BxPC-3/shLEF1, while BAX, Cleaved caspase-3 and <t>Cleaved</t> <t>caspase-9</t> increased (n = 3, * P <0.05, ** P <0.01).
    Cleaved Caspase 9, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cleaved+caspase+9/Cleaved+Caspase-9+(Asp353)+Antibody/pmc12975020-138-39-43
    Average 96 stars, based on 1 article reviews
    cleaved caspase 9 - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    99
    Cell Signaling Technology Inc cleavedcaspase
    Knockdown of LEF1 induces apoptosis in PAAD cells. A–C, Flow cytometry detection of apoptosis and apoptosis rate statistics: apoptosis rate was higher in AsPC-1/shLEF1 and BxPC-3/shLEF1. D–F, Calcein AM/PI staining assay results and statistics: the live cells decreased while the dead cells increased in AsPC-1/shLEF1 and BxPC-3/shLEF1. G, ATP production assay: the ATP production decreased in AsPC-1/shLEF1 and BxPC-3/shLEF1. H, LDH release assay showed an increase in LDH release in AsPC-1/shLEF1 and BxPC-3/shLEF1. I–M, WB results and quantitative analysis: the level of Bcl-2 protein decreased in AsPC-1/shLEF1 and BxPC-3/shLEF1, while BAX, Cleaved caspase-3 and <t>Cleaved</t> <t>caspase-9</t> increased (n = 3, * P <0.05, ** P <0.01).
    Cleavedcaspase, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cleaved+caspase+9/Cleaved+Caspase-3+(Asp175)+Rabbit+mAb/pm41897364-56-6-14
    Average 99 stars, based on 1 article reviews
    cleavedcaspase - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc caspase 9
    Knockdown of LEF1 induces apoptosis in PAAD cells. A–C, Flow cytometry detection of apoptosis and apoptosis rate statistics: apoptosis rate was higher in AsPC-1/shLEF1 and BxPC-3/shLEF1. D–F, Calcein AM/PI staining assay results and statistics: the live cells decreased while the dead cells increased in AsPC-1/shLEF1 and BxPC-3/shLEF1. G, ATP production assay: the ATP production decreased in AsPC-1/shLEF1 and BxPC-3/shLEF1. H, LDH release assay showed an increase in LDH release in AsPC-1/shLEF1 and BxPC-3/shLEF1. I–M, WB results and quantitative analysis: the level of Bcl-2 protein decreased in AsPC-1/shLEF1 and BxPC-3/shLEF1, while BAX, Cleaved caspase-3 and <t>Cleaved</t> <t>caspase-9</t> increased (n = 3, * P <0.05, ** P <0.01).
    Caspase 9, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cleaved+caspase+9/Cleaved+Caspase-9+(Asp315)+Rabbit+mAb/pm41892957-217-52-55
    Average 96 stars, based on 1 article reviews
    caspase 9 - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    Image Search Results


    mBH3@NPs preferentially induced mtApoptosis and immunogenic cell death in cancer cells (A) Flow cytometry analysis of cells positive for Annexin V and propidium iodide (PI) in cancer and non-cancer cell lines after treatment with PBS (control), NPs, naked Puma mRNA, and mPuma@NPs for 12 h ( n = 3). (B) Western blot analysis of mitochondrial apoptois pathway in CT-26 cells treated with control, NPs, mPuma@NPs, and mBim@NPs. Bax, Bcl-2, Bcl-x L , Mcl-1, caspase-3, cleaved caspase-3 (C-Cas3), caspase9, and cleaved caspase-9 (C-Cas9) proteins were detected. β-Actin was used as the loading control ( n = 3). (C) Confocal laser scanning microscopy (CLSM) images of the 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethyl-imidacarbocyanine (JC-1) probe in CT-26 cells after treatment with PBS (control), NPs, mPuma@NPs, and mBim@NPs for 12 h. Increased JC-1 monomer signal (green) and decreased JC-1 aggregate signal (red) indicate a decrease in mitochondrial membrane potential ( n = 3). Scale bars, 200 μm. (D) Flow cytometry analysis of cellular oxygen species (ROS) levels using 2,7-dichlorofluorescein diacetate (DCFH-DA) staining in CT-26 cells after 12 h incubation with PBS (control), NPs, naked mRNA, mPuma@NPs, and mBim@NPs ( n = 3). (E) CLSM images of CRT expression in B16-F10 and CT-26 cells after 12 h incubation with PBS (control), NPs, mPuma@NPs, and mBim@NPs ( n = 3). Scale bars, 20 μm. (F) Extracellular ATP and HMGB1 expression levels were analyzed by ELISA in B16-F10 cells after 12-h incubation with PBS (control), NPs, mPuma@NPs, and mBim@NPs ( n = 3). (G) Flow cytometry analysis and quantification of immune stimulation in BMDCs co-cultured with B16-F10 cells pretreated with PBS (control), NPs, mPuma@NPs, and mBim@NPs for 12 h, followed by 48-h co-culture ( n = 3). One-way ANOVA with Tukey’s multiple comparisons test was used for all statistical analyses. Data are presented as the mean ± SD. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; NS, not significant. See also  .

    Journal: Cell Reports Medicine

    Article Title: mRNA lipid-nanoparticle-mediated mitochondrial apoptosis augments adoptive T cell immunotherapy

    doi: 10.1016/j.xcrm.2026.102706

    Figure Lengend Snippet: mBH3@NPs preferentially induced mtApoptosis and immunogenic cell death in cancer cells (A) Flow cytometry analysis of cells positive for Annexin V and propidium iodide (PI) in cancer and non-cancer cell lines after treatment with PBS (control), NPs, naked Puma mRNA, and mPuma@NPs for 12 h ( n = 3). (B) Western blot analysis of mitochondrial apoptois pathway in CT-26 cells treated with control, NPs, mPuma@NPs, and mBim@NPs. Bax, Bcl-2, Bcl-x L , Mcl-1, caspase-3, cleaved caspase-3 (C-Cas3), caspase9, and cleaved caspase-9 (C-Cas9) proteins were detected. β-Actin was used as the loading control ( n = 3). (C) Confocal laser scanning microscopy (CLSM) images of the 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethyl-imidacarbocyanine (JC-1) probe in CT-26 cells after treatment with PBS (control), NPs, mPuma@NPs, and mBim@NPs for 12 h. Increased JC-1 monomer signal (green) and decreased JC-1 aggregate signal (red) indicate a decrease in mitochondrial membrane potential ( n = 3). Scale bars, 200 μm. (D) Flow cytometry analysis of cellular oxygen species (ROS) levels using 2,7-dichlorofluorescein diacetate (DCFH-DA) staining in CT-26 cells after 12 h incubation with PBS (control), NPs, naked mRNA, mPuma@NPs, and mBim@NPs ( n = 3). (E) CLSM images of CRT expression in B16-F10 and CT-26 cells after 12 h incubation with PBS (control), NPs, mPuma@NPs, and mBim@NPs ( n = 3). Scale bars, 20 μm. (F) Extracellular ATP and HMGB1 expression levels were analyzed by ELISA in B16-F10 cells after 12-h incubation with PBS (control), NPs, mPuma@NPs, and mBim@NPs ( n = 3). (G) Flow cytometry analysis and quantification of immune stimulation in BMDCs co-cultured with B16-F10 cells pretreated with PBS (control), NPs, mPuma@NPs, and mBim@NPs for 12 h, followed by 48-h co-culture ( n = 3). One-way ANOVA with Tukey’s multiple comparisons test was used for all statistical analyses. Data are presented as the mean ± SD. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; NS, not significant. See also .

    Article Snippet: Cleaved-Caspase 9 (Asp353) Antibody , Abmart , Cat#TA5240S; RRID:AB_3740854.

    Techniques: Flow Cytometry, Control, Western Blot, Confocal Laser Scanning Microscopy, Membrane, Staining, Incubation, Expressing, Enzyme-linked Immunosorbent Assay, Cell Culture, Co-Culture Assay

    CGF’s effect on cell cycle and apoptosis in CRC (A) Flow cytometry was used to analyze how CGF affects the cell cycle of HCT116 and HT29 cells at certain concentrations, with the percentage of cells in G1, S, and G2 phases shown in each panel. (B) Western blot analysis of the changes in cell cycle-related proteins CDK1, p-CDK1, and cyclin B1 in HCT116 and HT29 cells after CGF treatment. (C) RT-qPCR analysis of the relative expression levels of PUMA and NOXA genes in HCT116 and HT29 cells treated with different concentrations of CGF. (D) Western blot analysis of the changes in apoptosis-related proteins BCL2, PUMA, Noxa, C-caspase 9, and C-caspase 3 in HCT116 and HT29 cells after CGF treatment. (E) Flow cytometry was used to analyze apoptosis in HCT116 and HT29 cells treated with CGF. On the left is a representative plot showing apoptosis, utilizing Annexin V-FITC and PI double staining. Right: Analysis of early and late apoptosis in cells from each group using quantitative methods. (A–C and E) Data presentation is in the form of mean ± SEM. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; ∗∗∗∗ p < 0.0001.

    Journal: iScience

    Article Title: CGF induces ROS-mediated metabolic reprogramming and mitochondrial dysfunction to suppress colorectal cancer progression

    doi: 10.1016/j.isci.2026.115273

    Figure Lengend Snippet: CGF’s effect on cell cycle and apoptosis in CRC (A) Flow cytometry was used to analyze how CGF affects the cell cycle of HCT116 and HT29 cells at certain concentrations, with the percentage of cells in G1, S, and G2 phases shown in each panel. (B) Western blot analysis of the changes in cell cycle-related proteins CDK1, p-CDK1, and cyclin B1 in HCT116 and HT29 cells after CGF treatment. (C) RT-qPCR analysis of the relative expression levels of PUMA and NOXA genes in HCT116 and HT29 cells treated with different concentrations of CGF. (D) Western blot analysis of the changes in apoptosis-related proteins BCL2, PUMA, Noxa, C-caspase 9, and C-caspase 3 in HCT116 and HT29 cells after CGF treatment. (E) Flow cytometry was used to analyze apoptosis in HCT116 and HT29 cells treated with CGF. On the left is a representative plot showing apoptosis, utilizing Annexin V-FITC and PI double staining. Right: Analysis of early and late apoptosis in cells from each group using quantitative methods. (A–C and E) Data presentation is in the form of mean ± SEM. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; ∗∗∗∗ p < 0.0001.

    Article Snippet: Cleaved Caspase-9 (Asp315) (D8I9E) Rabbit mAb , CST , Cat # 20750; RRID:AB_2798848.

    Techniques: Flow Cytometry, Western Blot, Quantitative RT-PCR, Expressing, Double Staining

    The effect of CGF-induced ROS on the MAPK/ERK 1/2/c-MYC signaling pathway (A) Western blotting was used to analyze the expression of MEK, P-MEK, ERK 1/2, P-ERK 1/2, and c-MYC proteins in HCT116 and HT29 cells after treatment with specified CGF concentrations. (B) Immunofluorescence staining of HCT116 and HT29 cells after CGF treatment, showing changes in p-ERK (green). PMA was used to promote nuclear entry of p-ERK (200 nM, 4 h), and DAPI was used to stain the nucleus (blue), with merged images shown (scale bars, 10 μM). (C) Western blot was used to analyze the levels of MEK, P-MEK, ERK 1/2, P-ERK 1/2, and c-MYC proteins in HCT116 and HT29 cells following treatment with CGF (40 μM, 24 h) and NAC (500 μM, 24 h). (D) Untargeted metabolomics analysis of glycolytic metabolites after CGF treatment in HCT116 cells. Metabolites marked in blue represent those inhibited by CGF. (E and F) ELISA analysis of lactate secretion in the cell supernatant of HCT116 (E) and HT29 (F) cells after CGF treatment. (G and H) Analysis of mRNA expression levels of genes related to glycolysis in HCT116 and HT29 cells exposed to certain concentrations of CGF using RT-qPCR. (I) Western blot was used to analyze the expression levels of apoptosis-associated proteins (BCL2, PUMA, NOXA, C-caspase 9, and C-caspase 3) and EMT markers (N-cadherin and vimentin) in HCT116 and HT29 cells after they were treated with CGF. (J) Western blot analysis of the reversal of EMT markers N-cadherin, vimentin, SLUG, and SNAIL proteins in HCT116 and HT29 cells overexpressing c-MYC. (E–J) Data presentation is in the form of mean ± SEM. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; ∗∗∗∗ p < 0.0001.

    Journal: iScience

    Article Title: CGF induces ROS-mediated metabolic reprogramming and mitochondrial dysfunction to suppress colorectal cancer progression

    doi: 10.1016/j.isci.2026.115273

    Figure Lengend Snippet: The effect of CGF-induced ROS on the MAPK/ERK 1/2/c-MYC signaling pathway (A) Western blotting was used to analyze the expression of MEK, P-MEK, ERK 1/2, P-ERK 1/2, and c-MYC proteins in HCT116 and HT29 cells after treatment with specified CGF concentrations. (B) Immunofluorescence staining of HCT116 and HT29 cells after CGF treatment, showing changes in p-ERK (green). PMA was used to promote nuclear entry of p-ERK (200 nM, 4 h), and DAPI was used to stain the nucleus (blue), with merged images shown (scale bars, 10 μM). (C) Western blot was used to analyze the levels of MEK, P-MEK, ERK 1/2, P-ERK 1/2, and c-MYC proteins in HCT116 and HT29 cells following treatment with CGF (40 μM, 24 h) and NAC (500 μM, 24 h). (D) Untargeted metabolomics analysis of glycolytic metabolites after CGF treatment in HCT116 cells. Metabolites marked in blue represent those inhibited by CGF. (E and F) ELISA analysis of lactate secretion in the cell supernatant of HCT116 (E) and HT29 (F) cells after CGF treatment. (G and H) Analysis of mRNA expression levels of genes related to glycolysis in HCT116 and HT29 cells exposed to certain concentrations of CGF using RT-qPCR. (I) Western blot was used to analyze the expression levels of apoptosis-associated proteins (BCL2, PUMA, NOXA, C-caspase 9, and C-caspase 3) and EMT markers (N-cadherin and vimentin) in HCT116 and HT29 cells after they were treated with CGF. (J) Western blot analysis of the reversal of EMT markers N-cadherin, vimentin, SLUG, and SNAIL proteins in HCT116 and HT29 cells overexpressing c-MYC. (E–J) Data presentation is in the form of mean ± SEM. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; ∗∗∗∗ p < 0.0001.

    Article Snippet: Cleaved Caspase-9 (Asp315) (D8I9E) Rabbit mAb , CST , Cat # 20750; RRID:AB_2798848.

    Techniques: Western Blot, Expressing, Immunofluorescence, Staining, Enzyme-linked Immunosorbent Assay, Quantitative RT-PCR

    Knockdown of LEF1 induces apoptosis in PAAD cells. A–C, Flow cytometry detection of apoptosis and apoptosis rate statistics: apoptosis rate was higher in AsPC-1/shLEF1 and BxPC-3/shLEF1. D–F, Calcein AM/PI staining assay results and statistics: the live cells decreased while the dead cells increased in AsPC-1/shLEF1 and BxPC-3/shLEF1. G, ATP production assay: the ATP production decreased in AsPC-1/shLEF1 and BxPC-3/shLEF1. H, LDH release assay showed an increase in LDH release in AsPC-1/shLEF1 and BxPC-3/shLEF1. I–M, WB results and quantitative analysis: the level of Bcl-2 protein decreased in AsPC-1/shLEF1 and BxPC-3/shLEF1, while BAX, Cleaved caspase-3 and Cleaved caspase-9 increased (n = 3, * P <0.05, ** P <0.01).

    Journal: Pancreas

    Article Title: Knockdown of Lymphoid Enhancer-binding Factor 1 Inhibits Pancreatic Adenocarcinoma Growth and Neoangiogenesis by Curbing Notch1 and Nuclear Factor Kappa B Signaling Pathways

    doi: 10.1097/MPA.0000000000002562

    Figure Lengend Snippet: Knockdown of LEF1 induces apoptosis in PAAD cells. A–C, Flow cytometry detection of apoptosis and apoptosis rate statistics: apoptosis rate was higher in AsPC-1/shLEF1 and BxPC-3/shLEF1. D–F, Calcein AM/PI staining assay results and statistics: the live cells decreased while the dead cells increased in AsPC-1/shLEF1 and BxPC-3/shLEF1. G, ATP production assay: the ATP production decreased in AsPC-1/shLEF1 and BxPC-3/shLEF1. H, LDH release assay showed an increase in LDH release in AsPC-1/shLEF1 and BxPC-3/shLEF1. I–M, WB results and quantitative analysis: the level of Bcl-2 protein decreased in AsPC-1/shLEF1 and BxPC-3/shLEF1, while BAX, Cleaved caspase-3 and Cleaved caspase-9 increased (n = 3, * P <0.05, ** P <0.01).

    Article Snippet: The first antibodies were as follows: LEF1 (ab137872, 1:1000, Abcam), proliferating cell nuclear antigen (PCNA, ab29, 1:1000, Abcam), MMP-2 (4022S, 1:1000, CST), MMP-9 (3852S, 1:1000, CST), BAX (2772S, 1:1000, CST), Bcl-2 (15071S, 1:1000, CST), Cleaved caspase-3 (9661S, 1:1000, CST), Cleaved caspase-9 (9509S, 1:1000, CST), vascular endothelial growth factor-A (VEGFA, ab214424, 1:1000, Abcam), total Notch1 (ab52627, 1:1000, Abcam), NICD (4147, 1:1000, CST), Hes1 (ab71559, 1:1000, Abcam), Hey1 (ab235173, 1:1000, Abcam), Jagged1 (ab300561, 1:1000, Abcam), P65 (ab32536, 1:1000, Abcam), p-P65 (3033S, 1:1000, CST), GAPDH (5174S, 1:5000, CST), HRP-anti-Rabbit (A0362, 1:1000, Beyotime), HRP-anti-Mouse (A0350, 1:1000, Beyotime).

    Techniques: Knockdown, Flow Cytometry, Staining, Lactate Dehydrogenase Assay